Moores Cancer Center at the University of California San Diego has received a $1 million donation from pharmaceutical company ...

Fresh from the $43 billion acquisition of antibody-drug conjugate (ADC) specialist Seagen, Pfizer has laid out plans for its dedicated oncology division in front of investors, aiming to add eight ...

Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

What drew you to pursue a career in oncology and what is it that inspires you most about working in this field?

Try not to let market volatility bring you down. Instead, let dividend stocks make you happy. These high-yield dividend stocks will pay you between 3% and 7% to hold them.

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

Despite treatment advances, there is currently no cure. Dr Chris Boshoff, chief development officer, Oncology and Rare Disease, at Pfizer Global Product Development, said: “Today, multiple ...

Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...

Johnson & Johnson and Pfizer are two of the world's largest pharmaceutical companies with diversified healthcare portfolios.

With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...

Pfizer has unveiled its new research and development centre in Beijing, marking a significant step in the company's strategic expansion in China.